HAEK.HM Haemato AG

Healthcare Drug Manufacturers - Specialty & Generic Hamburg Exchange
13.23 EUR
Close of Nov 4, 2026
8.17 13.56
Market cap
EUR 69.2M
P/E
6.5x
P/B
0.66x
ROE
5.6%
Dividend yield
8.31%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2022.

Is HAEK.HM undervalued?

Graham number
Price13.23
Graham value30.40
Discount56.5%

HAEK.HM trades 56.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Haemato AG fundamental analysis

No fundamental analysis for Haemato AG yet.

Haemato AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Haemato AG

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, and special cosmetics, as well as dietary supplements. It also provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. In addition, it develops, ma…

Full company profile